🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Colon Disease

GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care NCT05391126NA1 site📍 Lexington Reema A. Patel · Tests: Irinotecan Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC NCT06553885Phase 21 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Enfortumab Vedotin Study of Treatment With Intensified Omeprazole Treatment to Prevent High Output Stoma 1 NCT06917963NA2 sites📍 Gdansk📍 Gdynia Medical University of Gdansk · Tests: Intensified intravenous omeprazole therapy (loading dose 80 mg IV, then 40 mg IV twice daily at 6:00 AM and 6:00 PM), S… The Ohio State University (OSU) SCREEN Community Program NCT06666192NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Cancer Screening, Discussion, Educational Activity, Educational Intervention, Focus Group A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers NCT06568016NA2 sites📍 Los Angeles📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Best Practice, Communication Intervention, Communication Intervention, Coordination, Educational Intervention Stopping PPI Therapy in Inactive IBD NCT07691138Phase 41 site📍 Nottingham University of Nottingham · Tests: Continue PPI Therapy, Withdraw PPI Therapy Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors NCT06821048Phase 11 site📍 Hangzhou Weijia Fang, MD · Tests: Intraperitoneal infusion of FAST CEA-targeted CAR-T NIMA-Colon Cancer Study NCT07534852NA1 site📍 Málaga Fundación Pública Andaluza para la Investigación de Málaga … · Tests: Standard hypercaloric-hyperproteic nutritional supplementation, HMB-enriched hypercaloric-hyperproteic nutritional supp… Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease NCT06607458Phase 220 sites📍 Duarte📍 Santa Monica📍 Miami Delcath Systems Inc. · Tests: Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab, Trifluridine-tipiracil … Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer NCT06509126Phase 31 site📍 Naples National Cancer Institute, Naples · Tests: Panitumumab, Irinotecan, 5-fluorouracil, L-folinic acid Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis NCT06453317Phase 21 site📍 Lodz Medical University of Lodz · Tests: Infliximab, Ustekinumab Impact of Diet and Lifestyle Modification on the Intestinal Barrier Integrity in Crohn's Disease NCT06719778NA1 site📍 Bamberg Universität Duisburg-Essen · Tests: Two-stage nutritional therapy concept Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors NCT07487168Phase 11 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Mitomycin C (MMC), Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation NCT07501078Phase 21 site📍 Ann Arbor Muhammad N Aslam, MD · Tests: Aquamin, Placebo Low Stable Pressure Pneumoperitoneum in Colorectal Surgery (CROSS STUDY) NCT06154785n/a18 sites📍 Jette📍 Besançon📍 Bordeaux Bordeaux Colorectal Institute Academy Advanced Therapies for Liver Metastases NCT04622423n/a1 site📍 Milan IRCCS San Raffaele Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation NCT07034443NA1 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: High Intensity Focused Electromagnetic Stimulation 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site📍 Beijing Peking University First Hospital · Tests: 18F-T2 PET/CT Digestive Enzyme Formulation Intervention in IBS Patients Who Previously Clinically Responded to Mediterranean LFD NCT06749613NA2 sites📍 Chaïdári📍 Athens Attikon Hospital · Tests: digestive enzymes Sacituzumab Govitecan in Metastatic Colorectal Cancer NCT06243393Phase 2, Phase 31 site📍 Heidelberg University Hospital Heidelberg · Tests: Sacituzumab Govitecan (SG), Physicians Choice (PhC). Probiotics and Biomarkers in Irritable Bowel Syndrome NCT07584278NA1 site📍 Gothenburg Sahlgrenska University Hospital · Tests: Probiotic Supplementation (Lactobacillus Reuteri), Placebo Supplementation Neoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer NCT07352280n/a1 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps NCT05080673NA493 sites📍 Fairbanks📍 Goodyear📍 Kingman NRG Oncology · Tests: 5-year and 10 Year Surveillance Colonoscopy after Qualifying Colonoscopy Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Randomized, Double-arm, Open-label Study NCT06896305NA1 site📍 Milan IRCCS Ospedale San Raffaele · Tests: CDED (Crohn's Disease Exclusion Diet) in addition to anti-TNF therapy, Anti-TNF Therapy Precision Navigation to Improve Community Cancer Screening Participation NCT07676383NA3 sites📍 Huaihua📍 Shaoyang📍 Yongzhou Hunan Cancer Hospital · Tests: Precision Navigation Intervention, Usual Health Education Comparing PP and PVDF Meshes in Midline Laparotomy Closure for High-risk Colorectal Surgery. Impact on Incisional Hernia and Surgical Wound Infection. NCT06220045NA1 site📍 Girona Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta · Tests: Polyvinylidene fluoride mesh, Prophylactic polypropylene mesh Single cEll pRofiling PErsistaNce To ImmuNothErapy NCT06680739Phase 21 site📍 Barcelona Vall d'Hebron Institute of Oncology · Tests: Durvalumab, Tremelimumab Duodenal Polyposis Classification in FAP NCT07199127n/a2 sites📍 Milan📍 Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Tests: DRACO Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial NCT06841705Phase 22 sites📍 Boston📍 Boston Shilpa Grover, MD, MPH · Tests: Vedolizumab 300 MG Injection [Entyvio], Prednisone (and methylprednisolone), Prednisone Taper, Placebo Prednisone Capsu…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy